Loading...
Aggressive Pricing In China Will Compress Margins Despite Clinical Promise
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
72.8%7D
5.9%1Y
72.8%7D
5.9%You can edit this narrative until Jun 21 10:13 PM. Then, changes will post as Updates.
You can edit this narrative until Jun 21 10:13 PM. Then, changes will post as Updates.